Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001399529-21-000109
Filing Date
2021-06-07
Accepted
2021-06-07 21:35:07
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162311608345843.html 4  
1 FORM 4 wf-form4_162311608345843.xml 4 11078
  Complete submission text file 0001399529-21-000109.txt   12287
Mailing Address
Business Address
KOZIN MARC D (Reporting) CIK: 0001241647 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 211001098

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations